Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope

Vaccine

Volumn 25, Issue 32, 2007, Pages 6070-6077

  Cheung, Ying Kit ^a   Cheng, Samuel Chak Sum ^a   Sin, Fion Wan Yee ^a   Chan, Kin Tak ^a   Xie, Yong ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Coronavirus; DNA vaccine; Severe acute respiratory syndrome (SARS); Single chain trimers (SCT)

Indexed keywords

ALANYLLEUCYLASPARAGINYLTHREONYLPROLYLLYSYLASPARTYLHISTIDYLISOLEUCINE; ARGINYLLEUCYLASPARAGINYLGLUTAMINYLLEUCYLGLUTAMYLSERYLLYSYLVALINE; EPITOPE; GLYCYLISOLEUCYLLEUCYLGLYCYLPHENYLALANYLVALYLPHENYLALANYLTHREONYLLEUCINE; GLYCYLMETHIONYLSERYLARGINYLISOLEUCYLGLYCYLMETHIONYLGLUTAMYLVALINE; HLA A ANTIGEN; HLA A0201 ANTIGEN; HLA A2 ANTIGEN; ISOLEUCYLLEUCYLLEUCYLASPARAGINYLLYSYLHISTIDYLISOLEUCYLASPARTYLALANINE; LEUCYLALANYLLEUCYLLEUCYLLEUCYLLEUCYLASPARTYLARGINYLLEUCINE; LEUCYLGLUTAMINYLLEUCYLPROLYLGLUTAMINYLGLYCYLTHREONYLTHREONYLLEUCINE; LEUCYLLEUCYLLEUCYLASPARTYLARGINYLLEUCYLASPARAGINYLGLUTAMINYLLEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOCAPSID PROTEIN; PET22B VECTOR; PLASMID VECTOR; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CONTROLLED STUDY; CORONAVIRUS; CYTOTOXICITY TEST; DRUG DESIGN; EFFECTOR CELL; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SEVERE ACUTE RESPIRATORY SYNDROME; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; NUCLEOCAPSID PROTEINS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL VACCINES;

EID: 34447505939     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.025     Document Type: Article

References (35)

1. Chan P.K., Tang J.W., and Hui D.S. SARS: clinical presentation, transmission, pathogenesis and treatment options. Clin Sci (Lond) 110 (2006) 193-204
2. Ng W.F., To K.F., Lam W.W., Ng T.K., and Lee K.C. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1-a review. Hum Pathol 37 (2006) 381-390
3. Poon L.L., Guan Y., Nicholls J.M., Yuen K.Y., and Peiris J.S. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect Dis 4 (2004) 663-671
4. Tan Y.J., Lim S.G., and Hong W. Characterization of viral proteins encoded by the SARS-coronavirus genome. Antiviral Res 65 (2005) 69-78
5. Ackerman A.L., and Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigen. Nat Immunol 5 (2004) 678-684
6. Seo S.H., Wang L., Smith R., and Collisson E.W. The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection. Virology 306 (2003) 376-384
7. Chunling M., Kun Y., Jian X., Jian Q., Hua S., and Minsheng Z. Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice. Intervirology 49 (2006) 307-318
8. Leung D.T., Tam F.C., Ma C.H., Chan P.K., Cheung J.L., Niu H., et al. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis 15 (2004) 379-386
9. Li S., Lin L., Wang H., Yin J., Ren Y., Zhao Z., et al. The epitope study on SARS-CoV nucleocapsid protein. Geno Prot Bioinform 1 (2003) 198-206
10. Shi Y., Wan Z., Li L., Li P., Li C., Ma Q., et al. Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients. J Clin Virol 31 (2004) 66-68
11. Shin G.C., Chung Y.S., Kim I.S., Cho H.W., and Kang C. Preparation and characterization of a novel monoclonal antibody specific to severe acute respiratory syndrome-coronavirus nucleocapsid protein. Virus Res 122 (2006) 109-118
12. Tsao Y.P., Lin J.Y., Jan J.T., Leng C.H., Chu C.C., Yang Y.C., et al. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochem Biophys Res Commun 344 (2006) 63-71
13. Wang Y.D., Sin W.Y., Xu G.B., Yang H.H., Wong T.Y., Pang X.W., et al. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. J Virol 78 (2004) 5612-5618
14. Zhou M., Xu D., Li X., Li H., Shan M., Tang J., et al. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. J Immunol 177 (2006) 2138-2145
15. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
16. Prabakaran P., Xiao X., and Dimitrov D.S. A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem Biophys Res Commun 314 (2004) 235-241
17. Holmes K.V. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest 111 (2003) 1605-1609
18. Ruan Y.J., Wei C.L., Ee A.L., Vega V.B., Thoreau H., Su S.T., et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361 (2003) 1779-1785
19. Huang C.H., Peng S., He L., Tsai Y.C., Boyd D.A., Hansen T.H., et al. Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope. Gene Ther 12 (2005) 1180-1186
20. Mottez E., Demoyen-Langlade P., Gournier H., Martinon F., Maryanski J., Kourilsky P., et al. Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic. J Exp Med 181 (1995) 493-498
21. Wong H.T., Cheng S.C.S., Chan E.W.C., Sheng Z.T., Yan W.Y., Zheng Z.X., et al. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune response in mice and protected swine against viral infection. Virology 278 (2000) 27-35
22. Chim S.S., et al. Genomic characterization of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong. Lancet 362 9398 (2003) 1807-1808
23. Lin K.Y., Guarnieri F.G., Staveley-O'Carroll K.F., Levitsky H.I., August J.T., Pardoll D.M., et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 56 (1996) 21-26
24. Chan R.C.F., Pang X.W., Wang Y.D., Chen W.F., and Xie Y. Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells. Br J Cancer 90 (2004) 1636-1643
25. Yu Y.Y., Netuschi N., Lybarger L., Connolly J.M., and Hansen T.H. Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J Immunol 168 (2002) 3145-3149
26. Pascolo S., Bervas N., Ure J.M., Smith A.G., Lemonnier F.A., and Perarnau B. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from β2-microglobulin (β2m) HLA-A2.1 monochain transgenic H-2Db β2m double knockout mice. J Exp Med 185 (1997) 2043-2051
27. Vitiello A., Marchesini D., Furze J., Sherman L.A., and Chesnut R.W. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med 173 (1991) 1007-1015
28. Bednarek M.A., Sauma S.Y., Gammon M.C., Porter G., Tamhankar S., Williamson A.R., et al. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J Immunol 147 (1991) 4047-4053
29. Jin H., Xiao C., Chen Z., Kang Y., Ma Y., Zhu K., et al. Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. Biochem Biophys Res Commun 328 (2005) 979-986
30. Peng H., Yang L.T., Wang L.Y., Li J., Huang J., Lu Z.Q., et al. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 351 2 (2006) 466-475
31. Dutoit V., Taub R.N., Papadopoulos K.P., Talbot S., Keohan M.L., Brehm M., et al. Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting. J Clin Invest 110 (2002) 1813-1822
32. Gngatic S., Atanackovic D., Matsuo M., Jager E., Lee S.Y., Valmori D., et al. Cross-presentation of HLA class IU epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APC. J Immunol 170 (2003) 1191-1196
33. Heit A., Huster K.M., Schmitz F., Schiemann M., Busch D.H., and Wagner H. CpG-DNA aided cross-priming by cross-presenting B cells. J Immunol 172 3 (2004) 1501-1507
34. Hon H., Oran A., Brocker T., and Jacob J. B lymphocytes participate in cross-presentation of antigen following gene gun vaccination. J Immunol 174 (2005) 5233-5242
35. Chen Z., Pei D., Jiang L., Song Y., Wang J., Wang H., et al. Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin Chem 50 (2004) 988-995